Hospital do Servidor Publico Estadual Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01693809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

caffeine (1 trial)

Drugs in Other Trials (2)

rivaroxaban (xarelto) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3